Predictors of optimal uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine and outcome of pregnancy in selected health facilities: a cross-sectional study in Northern Ghana

Table 5 Multivariable analysis for obstetric characteristics and birth outcomes influencing the uptake of optimal doses of SP

Characteristics SP 3 or more	Univariate regression		Multivariable regression	P-value
Characteristics SP 3 or more	cOR95% CI	P-value	aOR(95% CI)	P-value
Gravidae
Primigravidae	Ref		Ref
Secundigravidae	1.50(1.10–2.03)	0.010	0.76(0.40–1.45)	0.400
Multigravidae	1.13(0.88–1.45)	0.344	0.71(0.29–1.71)	0.443
Parity
Nulliparous	Ref		Ref
Primiparous	1.48(1.09–2.00)	0.011	1.62(0.85–3.08)	0.146
Multiparous	1.06(0.83–1.36)	0.616	1.25(0.52–3.02)	0.616
Number of ANC visit
1–3	Ref		Ref
4 +	3.50(2.49- 4.93)	< 0.001	1.65(1.11–2.45)	0.014
Trimester at 1st ANC
1st trimester	Ref		Ref
2nd trimester	0.49(0.39–0.62)	< 0.001	0.63(0.49–0.80)	< 0.001
3rd trimester	0.20(0.11–0.36)	< 0.001	0.38(0.19–0.75)	0.006
Malaria in pregnancy at 36 weeks of gestation
No	Ref		Ref
Yes	0.47(0.37–0.60)	< 0.001	0.56(0.43–0.73)	< 0.001
Anaemia in pregnancy at 36 weeks of gestation
No	Ref		Ref
Yes	0.54(0.43–0.68)	< 0.001	0.84(0.65–1.20)	0.201
Delivery of LBW babies
No	Ref		Ref
Yes	0.36(0.27–0.47)	< 0.001	0.47(0.34–0.64)	< 0.001
Delivery stillbirth babies
No	Ref		Ref
Yes	0.50(0.35–0.72)	< 0.001	0.87(0.57–1.31)	0.503

ISSN: 1475-2875